Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.
about
Molecular biomarkers for the detection of metastatic colorectal cancer cellsRole of β1-Integrin in Colorectal Cancer: Case-Control Study.Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer.Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.CTC enumeration and characterization: moving toward personalized medicine.Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.Assessment of tumor response to tyrosine kinase inhibitorsAssessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer.Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal CancersAssociation between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.Lymph node staging in colorectal cancer: old controversies and recent advances.Circulating tumor cells in gastrointestinal cancer.Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resectionPrognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review.Circulating Tumor Cells and Colorectal Cancer.Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.Biology and significance of circulating and disseminated tumour cells in colorectal cancer.Systematic review of sentinel lymph node mapping procedure in colorectal cancer.Epigenetics of regional lymph node metastasis in solid tumors.Prognostic biological features in neck dissection specimens.Enrichment, detection and clinical significance of circulating tumor cells.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.Circulating Tumor Cells In Colorectal Cancer.Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials.Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer.The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker.mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.A mathematical approach to the optimal examination of lymph nodes.The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer.Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.The Application of Gene Expression Profiling in Predictions of Occult Lymph Node Metastasis in Colorectal Cancer Patients.
P2860
Q27002450-8D10C59F-4761-41FF-9833-C4CA56F6E668Q33618904-E6B9DD87-00C2-4F8F-946E-4F583B8364ECQ33681010-FA3D7323-B05F-4472-AE03-2E88D3F3A74CQ33887066-FF109DDF-583A-4A61-B6D1-0081E9839BF4Q33898741-1B911330-EDF2-43DE-A08E-A311D42754BCQ34577724-B7E9F6B2-E874-4001-9595-85F905D67B6DQ35191893-CB25F28A-4600-4F6F-8757-837A7DDFCBB4Q35558589-BB7EA105-064E-4C4E-8546-784E95549375Q35874030-7740C066-C633-4946-85A2-B40700C48D6AQ35942178-DD64A00E-D2F5-42C8-9267-21ECC2DD8446Q36071446-DAA6262E-EBCC-4ED3-B760-96CACD674B25Q36289304-212E3420-A9F2-45BE-9FED-9560CD6E0A6DQ36339707-17708F75-BB39-49FC-9588-0C9FC6BE32B3Q37408817-9E14F622-E0E2-40A7-B313-F52921B3666EQ37610814-20B80DE2-796A-4FB2-97D9-0191784BE4D0Q37688082-D0766ED8-BEE8-45B1-9170-61C05C6CC102Q37730438-FEE6F919-FBC0-4A58-8A03-B2F778A7C2D0Q37796603-ACCD0054-83FC-4112-B54A-58E279AFA2C7Q37890969-33A712FD-B03D-4E18-84DA-A01E2624D7EEQ37898107-556DA473-8DBE-4557-A967-B582FCB0859DQ37986595-4646091C-6CBA-4ACB-B3F4-B11CEA934271Q38014330-809DD366-9A7B-4C0C-8C6D-CAF0CF83D6E4Q38017604-9FE12ACA-C0EA-48D4-9135-20461F83BAC0Q38043916-79BCCD88-329C-4E25-AE00-E959F0C63D3DQ38102590-00FC618B-2078-43B2-A41B-4F49778F15D1Q38152782-672EDB72-0FB3-4494-96BF-9EC30C939518Q38227766-7230B2B5-3385-4E7D-B6AF-C73DEA2E0FA1Q38546739-64164B54-C097-496E-90A9-024C95C67FAFQ38577436-8310BF05-990A-4422-81DB-0DFBC3E4245AQ38621235-97767ACB-7DB1-4DDA-B438-3B1CDC4F1D52Q39084174-E086779A-F2AA-464B-B010-3A2C627F8FBFQ40769679-A2B82E35-71E6-4870-980B-BFAFFFCDA90FQ41136311-20BA9B0A-9019-463D-9319-56F4579F0775Q42585781-6AC932DB-15FD-475E-A2B6-EB7B4B2E9320Q50212352-692A1F93-E79F-413B-AEA8-71DD2CF08919Q51497835-B628EB6D-0F20-432A-9AD6-ADE4D7D07054Q52688050-85D8AED6-B8AE-4CAE-B773-F339DB72985BQ54327711-76A4D023-5FF7-4FC4-9C91-65F1B94A0CDDQ54500317-D1D1BEDA-9188-4E26-81BB-5797E82305D0Q54693967-F49F049E-4EFC-47B7-A2CF-218C1FF7859F
P2860
Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prognostic relevance of occult ...... prospective multicenter trial.
@en
Prognostic relevance of occult ...... prospective multicenter trial.
@nl
type
label
Prognostic relevance of occult ...... prospective multicenter trial.
@en
Prognostic relevance of occult ...... prospective multicenter trial.
@nl
prefLabel
Prognostic relevance of occult ...... prospective multicenter trial.
@en
Prognostic relevance of occult ...... prospective multicenter trial.
@nl
P2093
P2860
P1476
Prognostic relevance of occult ...... prospective multicenter trial.
@en
P2093
Anton J Bilchik
Dave S B Hoon
David Elashoff
David Wiese
Kazuo Koyanagi
Linda Deacon
Martin McCarter
Perry Shen
Roderick R Turner
Sukamal Saha
P2860
P304
P356
10.1158/1078-0432.CCR-08-0290
P407
P577
2008-11-01T00:00:00Z